Andreas Luch

Andreas Luch

Auto-generated profile, based on publicly available information

Andreas Luch

Institute of Toxicology, University of Mainz , Obere Zahlbacher Str. 67, D-55131, Mainz, FRG

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 1997 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
ALAndreas Luch
Andreas Luch
ASAlbrecht Seidel
Albrecht Seidel
HGHansruedi Glatt
Hansruedi Glatt
KPKarl L. Platt
Karl L. Platt

1 November 1996 in Polycyclic Aromatic Compounds
Verified
Journal Article
Closed access
HFHeinz Frank
Heinz Frank
ALAndreas Luch
Andreas Luch
FOFranz Oesch
Franz Oesch
ASAlbrecht Seidel
Albrecht Seidel
Absolute configuration was assigned to the enantiomers of the metabolically formed trans-11,12-dihydrodiol of dibenzo[a,l]pyrene by application of a CD spectroscopic method. For this purpose (±)-trans-11,12-dihydrodiol was converted to its diastereomeric bis(menthoxyacetates) followed by preparative separation of the diastereomers on silica gel. Hydrolysis of the two diastereomers gave the (+)- and (−)-11,12-dihydrodiols. To achieve assignment of the absolute configuration by the nonempirical exciton chirality method both the (+)- and (−)-dihydrodiol were transformed to their bis-4[4′-(dimethylamino)phenylazo]benzoates. The CD spectra of the bis-4[4′-(dimethylamino)phenylazo]benzoates revealed that (R,R)-configuration is associated with the (−)-11,12-dihydrodiol, whereas the (+)-11,12-dihydrodiol possesses (S,S)-configuration. Based on this assignment the absolute structures of the stereoselectively synthesized enantiomeric fjord-region 11,12-dihydrodiol 13,14-epoxides being potential ultimate carcinogenic metabolites of DB[a,l]P have also been unequivocally determined.


1 March 2005 in Polycyclic Aromatic Compounds
Verified
Journal Article
Closed access
TMTamara Musafija-Jeknic
Tamara Musafija-Jeknic
ALAndreas Luch
Andreas Luch
ASAlbrecht Seidel
Albrecht Seidel
CJChristopher Johns
Christopher Johns
CPClifford Pereira
Clifford Pereira
WBWilliam M. Baird
William M. Baird
Seven selfcomplementary decamer oligodeoxyribonucleotides were reacted with (–)–anti–(11R,12S)–dihydrodiol (13S,14R)–epoxide of dibenzo[a,l]pyrene (DB[a,l]PDE). The oligodeoxyribonucleotides were postlabeled with 33P–ATP, digested to mononucleotides and the amount of adducts formed was determined by HPLC. We found that the nucleotide sequence affects the binding of DB[a,l]PDE to DNA. DB[a,l]PDE binds better to GC rich oligodeoxyribonucleotides than to AT rich oligodeoxyribonucleotides. The CGC sequence binds more DB[a,l]PDE than GGC, TGC, GAT or AGC sequences. The reactions were carried out on ice or at 37°C. There was no evidence of temperature effects on the amount of DB[a,l]PDE binding.

1 November 1996 in Polycyclic Aromatic Compounds
Verified
Journal Article
Closed access
ALAndreas Luch
Andreas Luch
ASAlbrecht Seidel
Albrecht Seidel
HGHansruedi Glatt
Hansruedi Glatt
FOFranz Oesch
Franz Oesch
KPKarl L. Platt
Karl L. Platt
In vitro studies on the hepatic biotransformation of the enantiomeric trans-11,12-dihydrodiols of dibenzo[a,l]pyrene (DB[a,l]P) using microsomal fractions of animals pretreated with Aroclor 1254 revealed that the formation of fjord-region dihydrodiol epoxides strongly depends on the absolute configuration of the substrate. Both the (-)-11R,12R- and the (+)-11S,12S-enantiomer are converted diastereoselectively to the (-)- and (+)-anti-dihydrodiol epoxide, respectively, by either rat or mouse liver microsomes. Fjord-region oxidation occurs to greatest extent on incubation of the (-)-11R,12R-dihydrodiol with preparations from rats. This finding is in line with the differences seen for the two enantiomers on the total DNA binding under identical activation conditions as well as on the mutagenic activity in Chinese hamster V79 cells using the postmitochondrial hepatic fraction of Aroclor 1254-treated rats as metabolizing system.